临床实践中的知情同意及其困境探讨

Discussion on Informed Consent in Clinical Practice and Its Dilemma

知情同意与西方医学同根同源,伴随着西方医学发展的整个历程。知情同意由知情和同意两部分组成,其中,让患方充分知情是前提,在此基础上,患方同意或做出其他决定是结果。患方知情同意权在我国出现得比较晚,《中华人民共和国侵权责任法》第一次在法律上明确了我国患者的知情同意权。知情同意在临床实践中的实施与推广,在很大程度上保护了患方掌握医疗信息的自主权,赋予了患方参与患者所患疾病医疗决策的主体性与合法性。但临床实践中医疗决策是一个复杂的过程,受到心理、知识、文化等许多因素影响,在临床执行中常会面临很多困境。现对其进行探讨。

Informed consent has the same root and the same origin as Western medicine,and accompanies the whole course of the development of Western medicine.Informed consent consists of two parts:informed and consent,among which,let the patient fully know is the prerequisite,and on this basis,the patient’s consent or other decision is the result.The patient’s right of informed consent appeared relatively late in my country,and the"People’s Republic of China Tort Liability Law"legally clarified the patient’s right of informed consent for the first time in law.The implementation and promotion of informed consent in clinical practice protects the autonomy of patients in obtaining medical information to a large extent,and gives patients the subjectivity and legitimacy to participate in the medical decision-making of patients suffering from diseases.However,medical decision-making in clinical practice is a complex process,which is affected by many factors such as psychology,knowledge,and culture,and often faces many difficulties in clinical implementation.Discuss it now.